Skip to Content

TEVA 7334 (Mycophenolate Mofetil 250 mg)

Pill with imprint TEVA 7334 is Blue & Orange, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Teva Pharmaceuticals USA.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; bullous pemphigoid; autoimmune hepatitis; organ transplant, rejection prophylaxis; cogan's syndrome (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7334

Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil 250 mg TEVA 7334

Mycophenolate Mofetil

Imprint:
TEVA 7334
Strength:
250 mg
Color:
Blue & Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide